Peripheral T-cell lymphomas (PTCLs) are rare, aggressive lymphomas that affect mature T cells. “Peripheral” means the cancer developed from lymphoid tissue outside the thymus. This cancer is a subtype ...
Phase 2 PRIMO sub-analysis highlights outcomes with duvelisib in patients with peripheral T-cell lymphoma who proceeded to stem cell ...
Recently published PTCL Market Insights report includes a comprehensive understanding of current treatment practices, peripheral T-cell lymphoma emerging drugs, market share of individual therapies, ...
RMAT designation provides early and frequent FDA engagement to support planned pivotal development of Senza5 CART5 Therapy may be eligible for ...
Clinicians have documented a rare case of subcutaneous panniculitis-like T cell lymphoma in a patient receiving anti-CD20 ...
A 61-year-old man had a 2-year history of painful mucosal lesions and pruritic violaceous plaques on the trunk and ...
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas - blood cancers that arise in immune cells called B cells - yet the same is not true for ...
Columbia University investigators report an increased risk of breast lymphomas after postmastectomy implant-based reconstruction, including anaplastic large-cell lymphoma and several B-cell and T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results